home / stock / lly / lly articles

LLY Articles, Eli Lilly and Company - From 06/25/24

Stock Information
Company Name: Eli Lilly and Company
Stock Symbol: LLY
Market: NYSE
Website: lilly.com
Menu
LLY LLY Quote LLY Short LLY News LLY Articles LLY Message Board
Get LLY Alerts

News, Short Squeeze, Breakout and More Instantly...
Novo Nordisk's Older Generation Weight-Loss Drug Saxenda Associated With Decreased Bone Mass Density, Study Shows | Benzinga

In a new study published in the JAMA Network Open medical journal, Novo Nordisk A/S’s (NYSE:NVO) Saxenda (liraglutide), an earlier-generation...
What's Going On With Eli Lilly Stock On Tuesday? | Benzinga

On Tuesday, Eli Lilly and Co (NYSE:LLY) announced a collaboration with Microsoft Corp (NASDAQ:MSFT)-backed OpenAI that will allow Lilly to lev...

What's Going On With Eli Lilly Shares Monday? | Benzinga

Eli Lilly and Co (NYSE:LLY) shares are moving higher Monday following the release of positive Phase 3 trial results for its weight loss drug, tirze...

Why ResMed Shares Are Trading Lower Monday | Benzinga

ResMed, Inc. (NYSE:RMD) stock is trading lower Monday after Eli Lilly and Company (NYSE:LLY) released data from a clinical trial in regards to the ...
Will Novo Nordisk Building Fires Serve As A Catalyst For Eli Lilly? Redditors See A Stock Split For US Company 'Very Likely' | Benzinga

Eli Lilly And Co (NYSE:LLY) might see a significant boost due to supply issues at competitor Novo Nordisk A/S (NYSE:NVO), according to Reddit user ...

Eli Lilly's Zepbound For Weight Loss Shows Disease Resolution In Obese Sleep Apnea Patients, Lays Further Groundwork For Label Expansion | Benzinga

On Friday, Eli Lilly And Co (NYSE:LLY) released detailed results from the SURMOUNT-OSA phase 3 trials evaluating tirzepatide injection (10 mg or 1...

The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly | Benzinga

For Immediate Release Chicago, IL – June 21, 2024 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the ...
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments | Benzinga

Gilead Sciences, Inc. (NASDAQ:GILD) witnessed a flurry of Wall Street speculation regarding its potential involvement in the obesity drug market. B...

Move Aside Ozempic, WeGovy: Denmark's New Drug Just Showed Positive Results For Weightloss | Benzinga

Danish biotech company Zealand Pharma A/S (OTC:ZLDPF) has announced encouraging topline results from a Phase 1b multiple ascending dose (MAD) trial...

Nestle Carefully Targets Weight-Loss Drug Users with New Food Line | Benzinga

Last month, Nestlé SA (OTC:NSRGF) (OTC:NSRGY) unveiled Vital Pursuit, a new line of foods designed to complement GLP-1 weight loss ...
Previous 10 Next 10